Air Idle NEW Control US 16022PLCJ01 1.7L EL Acura Civic Honda 01-05 For Valve Car & Truck Fuel Inject. Controls & Parts


  1. Home
  2. Air Idle NEW Control US 16022PLCJ01 1.7L EL Acura Civic Honda 01-05 For Valve
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
NEW Idle Air Control Valve For 01-05 Honda Civic Acura EL 1.7L 16022PLCJ01 US
Condition: New Brand:

Unbranded

Other Part Number: 16022PLCJ01 Interchange Part Number: AC484, AC4211, 2H1114
Warranty: 90 Day Manufacturer Part Number:

16022PLCJ01

UPC:

Does not apply








published on tue nov 09 2021

Air Idle NEW Control US 16022PLCJ01 1.7L EL Acura Civic Honda 01-05 For Valve Car & Truck Fuel Inject. Controls & Parts

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Air Idle NEW Control US 16022PLCJ01 1.7L EL Acura Civic Honda 01-05 For Valve Car & Truck Fuel Inject. Controls & Parts

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS